Free Access
Volume 24, Number 1, Janvier 2015
Page(s) 1 - 3
Section Éditorial / Editorial
Published online 20 December 2014
  • Nair GB, Niederman MS (2014) Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med [in press] [Google Scholar]
  • American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416 [CrossRef] [PubMed] [Google Scholar]
  • Heyland DK, Dodek P, Muscedere J, et al (2008) Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 36:737–744 [CrossRef] [PubMed] [Google Scholar]
  • Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al (2007) Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 35:1888–1895 [CrossRef] [PubMed] [Google Scholar]
  • Ferrer M, Liapikou A, Valencia M, et al (2010) Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Clin Infect Dis 50:945–952 [CrossRef] [PubMed] [Google Scholar]
  • Wilke M, Grube RF, Bodmann KF (2011) Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilatorassociated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy. Eur J Med Res 16:315–323 [CrossRef] [PubMed] [Google Scholar]
  • Kumar A, Zarychanski R, Light B, et al (2010) Early combination antibiotic therapy yields improved survival compared with mono-therapy in septic shock: a propensity-matched analysis. Crit Care Med 38:1773–1785 [CrossRef] [PubMed] [Google Scholar]
  • Gribble MJ, Chow AW, Naiman SC, et al (1983) Prospective randomized trial of piperacillin monotherapy versus carboxypenicillinaminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob Agents Chemother 24:388–393 [CrossRef] [PubMed] [Google Scholar]
  • EORTC (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med 317:1692–1698 [CrossRef] [PubMed] [Google Scholar]
  • Calandra T, Glauser MP (1986) Immunocompromised animal models for the study of antibiotic combinations. Am J Med 80:45–52 [CrossRef] [Google Scholar]
  • Nseir S, Di Pompeo C, Soubrier S, et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289 [CrossRef] [PubMed] [Google Scholar]
  • Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668 [CrossRef] [PubMed] [Google Scholar]
  • Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4:519–527 [CrossRef] [PubMed] [Google Scholar]
  • Durante-Mangoni E, Signoriello G, Andini R, et al (2013) Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 57:349–358 [CrossRef] [PubMed] [Google Scholar]
  • Brunkhorst FM, Oppert M, Marx G, et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307:2390–2399 [CrossRef] [PubMed] [Google Scholar]
  • Razazi K, Brun-Buisson C (2014) Désescalade de l’antibiothérapie en réanimation. Réanimation 23:278–283 [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.